Medical devices
Kaleidoscope, Surge, Optellum, Cionic and Arcascope also announce funding rounds.
The company’s device, Primary Relief, is the latest of DyAnsys’ long list of devices to receive FDA clearance.
Device Connect for Fitbit aims to help healthcare and life science organizations use and analyze data from Fitbit's health-tracking wearables.
The company’s Seer Home device allows for potential epilepsy diagnosis through at-home data collection.
The company will use the funding to support the commercial expansion of its product.
The company said the clearance will allow more pharma companies to use Tasso+ for decentralized clinical trials.
It is currently conducting clinical studies and expanding its teams in Australia and the US.
The Series 8 includes two temperature sensors that can be used to retrospectively estimate when ovulation occurred.
The solution screens for plus disease, which is associated with severe ROP.
Credentialing and licensing platform CertifyOS scooped up $14.5 million, and patient engagement and navigation platform Upfront raised $10.5 million.